In addition, future research should also focus on developing nanomaterials for duplicating the action of other enzymes which are relevant in cancer and bacterial diseases such as asparaginase, glutaminase, lysozyme, etc. In addition, more research effort should be invested in nanozymatic reversal of drug resistance mechanisms, such as by showing cytidine deaminase-like behavior. The gene discussed is CDA; the disease is cancer.